nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—DHFR—Methotrexate—lymphatic system cancer	0.32	0.399	CbGbCtD
Trimethoprim—TYMS—Methotrexate—lymphatic system cancer	0.223	0.278	CbGbCtD
Trimethoprim—CYP2C9—Teniposide—lymphatic system cancer	0.0605	0.0754	CbGbCtD
Trimethoprim—ABCB1—Mitoxantrone—lymphatic system cancer	0.041	0.0512	CbGbCtD
Trimethoprim—CYP3A4—Cytarabine—lymphatic system cancer	0.0357	0.0445	CbGbCtD
Trimethoprim—CYP3A4—Teniposide—lymphatic system cancer	0.0352	0.0439	CbGbCtD
Trimethoprim—ABCB1—Vincristine—lymphatic system cancer	0.0282	0.0352	CbGbCtD
Trimethoprim—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0246	0.0307	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—lymphatic system cancer	0.0171	0.0213	CbGbCtD
Trimethoprim—CYP3A4—Vincristine—lymphatic system cancer	0.0169	0.0211	CbGbCtD
Trimethoprim—TYMS—Podofilox—Teniposide—lymphatic system cancer	0.0025	0.4	CbGdCrCtD
Trimethoprim—TYMS—Vinorelbine—Vincristine—lymphatic system cancer	0.00149	0.238	CbGdCrCtD
Trimethoprim—TYMS—Vinblastine—Vincristine—lymphatic system cancer	0.00103	0.164	CbGdCrCtD
Trimethoprim—Haematuria—Bleomycin—lymphatic system cancer	0.000734	0.00382	CcSEcCtD
Trimethoprim—Pruritus—Mechlorethamine—lymphatic system cancer	0.000731	0.0038	CcSEcCtD
Trimethoprim—Anorexia—Teniposide—lymphatic system cancer	0.000726	0.00377	CcSEcCtD
Trimethoprim—Cough—Fludarabine—lymphatic system cancer	0.000716	0.00372	CcSEcCtD
Trimethoprim—Pancytopenia—Carmustine—lymphatic system cancer	0.000716	0.00372	CcSEcCtD
Trimethoprim—Convulsion—Fludarabine—lymphatic system cancer	0.000711	0.00369	CcSEcCtD
Trimethoprim—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000707	0.00368	CcSEcCtD
Trimethoprim—Neutropenia—Carmustine—lymphatic system cancer	0.000705	0.00366	CcSEcCtD
Trimethoprim—Arthralgia—Fludarabine—lymphatic system cancer	0.000699	0.00363	CcSEcCtD
Trimethoprim—Myalgia—Fludarabine—lymphatic system cancer	0.000699	0.00363	CcSEcCtD
Trimethoprim—Pancytopenia—Vincristine—lymphatic system cancer	0.000683	0.00355	CcSEcCtD
Trimethoprim—Dyspnoea—Teniposide—lymphatic system cancer	0.000679	0.00353	CcSEcCtD
Trimethoprim—Pneumonia—Carmustine—lymphatic system cancer	0.000676	0.00351	CcSEcCtD
Trimethoprim—Confusional state—Fludarabine—lymphatic system cancer	0.000675	0.00351	CcSEcCtD
Trimethoprim—Neutropenia—Vincristine—lymphatic system cancer	0.000673	0.0035	CcSEcCtD
Trimethoprim—Depression—Carmustine—lymphatic system cancer	0.00067	0.00348	CcSEcCtD
Trimethoprim—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00067	0.00348	CcSEcCtD
Trimethoprim—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000665	0.00346	CcSEcCtD
Trimethoprim—Decreased appetite—Teniposide—lymphatic system cancer	0.000662	0.00344	CcSEcCtD
Trimethoprim—Renal failure—Carmustine—lymphatic system cancer	0.000661	0.00343	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000659	0.00342	CcSEcCtD
Trimethoprim—Vomiting—Mechlorethamine—lymphatic system cancer	0.000657	0.00342	CcSEcCtD
Trimethoprim—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000657	0.00341	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000657	0.00341	CcSEcCtD
Trimethoprim—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000656	0.00341	CcSEcCtD
Trimethoprim—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000655	0.00341	CcSEcCtD
Trimethoprim—Stomatitis—Carmustine—lymphatic system cancer	0.000655	0.0034	CcSEcCtD
Trimethoprim—Rash—Mechlorethamine—lymphatic system cancer	0.000652	0.00339	CcSEcCtD
Trimethoprim—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000651	0.00338	CcSEcCtD
Trimethoprim—Pneumonia—Vincristine—lymphatic system cancer	0.000645	0.00335	CcSEcCtD
Trimethoprim—Depression—Vincristine—lymphatic system cancer	0.00064	0.00332	CcSEcCtD
Trimethoprim—Anorexia—Fludarabine—lymphatic system cancer	0.000638	0.00332	CcSEcCtD
Trimethoprim—TYMS—Azacitidine—Fludarabine—lymphatic system cancer	0.000636	0.102	CbGdCrCtD
Trimethoprim—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000629	0.00327	CcSEcCtD
Trimethoprim—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000628	0.00327	CcSEcCtD
Trimethoprim—Feeling abnormal—Teniposide—lymphatic system cancer	0.000628	0.00326	CcSEcCtD
Trimethoprim—Stomatitis—Vincristine—lymphatic system cancer	0.000625	0.00325	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000623	0.00324	CcSEcCtD
Trimethoprim—Renal failure—Mitoxantrone—lymphatic system cancer	0.000614	0.00319	CcSEcCtD
Trimethoprim—Nausea—Mechlorethamine—lymphatic system cancer	0.000614	0.00319	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00061	0.00317	CcSEcCtD
Trimethoprim—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000609	0.00316	CcSEcCtD
Trimethoprim—Urticaria—Teniposide—lymphatic system cancer	0.000605	0.00315	CcSEcCtD
Trimethoprim—Glossitis—Methotrexate—lymphatic system cancer	0.000604	0.00314	CcSEcCtD
Trimethoprim—Abdominal pain—Teniposide—lymphatic system cancer	0.000602	0.00313	CcSEcCtD
Trimethoprim—Body temperature increased—Teniposide—lymphatic system cancer	0.000602	0.00313	CcSEcCtD
Trimethoprim—Erythema—Bleomycin—lymphatic system cancer	0.000602	0.00313	CcSEcCtD
Trimethoprim—TYMS—Azacitidine—Cytarabine—lymphatic system cancer	0.000601	0.096	CbGdCrCtD
Trimethoprim—Hallucination—Carmustine—lymphatic system cancer	0.0006	0.00312	CcSEcCtD
Trimethoprim—Dyspnoea—Fludarabine—lymphatic system cancer	0.000597	0.0031	CcSEcCtD
Trimethoprim—Haematuria—Mitoxantrone—lymphatic system cancer	0.000596	0.0031	CcSEcCtD
Trimethoprim—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000593	0.00308	CcSEcCtD
Trimethoprim—Dyspepsia—Fludarabine—lymphatic system cancer	0.00059	0.00306	CcSEcCtD
Trimethoprim—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.000588	0.00306	CcSEcCtD
Trimethoprim—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000583	0.00303	CcSEcCtD
Trimethoprim—Decreased appetite—Fludarabine—lymphatic system cancer	0.000582	0.00303	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000578	0.003	CcSEcCtD
Trimethoprim—Hallucination—Vincristine—lymphatic system cancer	0.000573	0.00298	CcSEcCtD
Trimethoprim—Constipation—Fludarabine—lymphatic system cancer	0.000573	0.00298	CcSEcCtD
Trimethoprim—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000569	0.00296	CcSEcCtD
Trimethoprim—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000566	0.00294	CcSEcCtD
Trimethoprim—Urethral disorder—Vincristine—lymphatic system cancer	0.000565	0.00293	CcSEcCtD
Trimethoprim—Eye disorder—Carmustine—lymphatic system cancer	0.000564	0.00293	CcSEcCtD
Trimethoprim—Hypersensitivity—Teniposide—lymphatic system cancer	0.000561	0.00292	CcSEcCtD
Trimethoprim—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000552	0.00287	CcSEcCtD
Trimethoprim—Pruritus—Teniposide—lymphatic system cancer	0.000539	0.0028	CcSEcCtD
Trimethoprim—Leukopenia—Bleomycin—lymphatic system cancer	0.000539	0.0028	CcSEcCtD
Trimethoprim—Body temperature increased—Fludarabine—lymphatic system cancer	0.000529	0.00275	CcSEcCtD
Trimethoprim—Mental disorder—Carmustine—lymphatic system cancer	0.000529	0.00275	CcSEcCtD
Trimethoprim—Erythema—Carmustine—lymphatic system cancer	0.000525	0.00273	CcSEcCtD
Trimethoprim—Malnutrition—Carmustine—lymphatic system cancer	0.000525	0.00273	CcSEcCtD
Trimethoprim—Cough—Bleomycin—lymphatic system cancer	0.000525	0.00273	CcSEcCtD
Trimethoprim—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000522	0.00272	CcSEcCtD
Trimethoprim—Diarrhoea—Teniposide—lymphatic system cancer	0.000521	0.00271	CcSEcCtD
Trimethoprim—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000519	0.0027	CcSEcCtD
Trimethoprim—Myalgia—Bleomycin—lymphatic system cancer	0.000512	0.00266	CcSEcCtD
Trimethoprim—Mental disorder—Vincristine—lymphatic system cancer	0.000505	0.00262	CcSEcCtD
Trimethoprim—Confusional state—Bleomycin—lymphatic system cancer	0.000495	0.00257	CcSEcCtD
Trimethoprim—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000493	0.00256	CcSEcCtD
Trimethoprim—Tremor—Carmustine—lymphatic system cancer	0.000492	0.00256	CcSEcCtD
Trimethoprim—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000491	0.00255	CcSEcCtD
Trimethoprim—Erythema—Mitoxantrone—lymphatic system cancer	0.000488	0.00254	CcSEcCtD
Trimethoprim—Vomiting—Teniposide—lymphatic system cancer	0.000485	0.00252	CcSEcCtD
Trimethoprim—Agitation—Carmustine—lymphatic system cancer	0.000483	0.00251	CcSEcCtD
Trimethoprim—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000481	0.0025	CcSEcCtD
Trimethoprim—Rash—Teniposide—lymphatic system cancer	0.00048	0.0025	CcSEcCtD
Trimethoprim—Dermatitis—Teniposide—lymphatic system cancer	0.00048	0.00249	CcSEcCtD
Trimethoprim—Headache—Teniposide—lymphatic system cancer	0.000477	0.00248	CcSEcCtD
Trimethoprim—Pruritus—Fludarabine—lymphatic system cancer	0.000474	0.00246	CcSEcCtD
Trimethoprim—Leukopenia—Carmustine—lymphatic system cancer	0.00047	0.00244	CcSEcCtD
Trimethoprim—Anorexia—Bleomycin—lymphatic system cancer	0.000468	0.00243	CcSEcCtD
Trimethoprim—Agitation—Vincristine—lymphatic system cancer	0.000461	0.00239	CcSEcCtD
Trimethoprim—Photosensitivity—Methotrexate—lymphatic system cancer	0.00046	0.00239	CcSEcCtD
Trimethoprim—Diarrhoea—Fludarabine—lymphatic system cancer	0.000458	0.00238	CcSEcCtD
Trimethoprim—Convulsion—Carmustine—lymphatic system cancer	0.000455	0.00236	CcSEcCtD
Trimethoprim—Nausea—Teniposide—lymphatic system cancer	0.000453	0.00235	CcSEcCtD
Trimethoprim—Vertigo—Vincristine—lymphatic system cancer	0.00045	0.00234	CcSEcCtD
Trimethoprim—Leukopenia—Vincristine—lymphatic system cancer	0.000449	0.00233	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000447	0.00232	CcSEcCtD
Trimethoprim—Myalgia—Carmustine—lymphatic system cancer	0.000447	0.00232	CcSEcCtD
Trimethoprim—Anxiety—Carmustine—lymphatic system cancer	0.000446	0.00232	CcSEcCtD
Trimethoprim—Dyspnoea—Bleomycin—lymphatic system cancer	0.000438	0.00228	CcSEcCtD
Trimethoprim—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000437	0.00227	CcSEcCtD
Trimethoprim—Convulsion—Vincristine—lymphatic system cancer	0.000434	0.00226	CcSEcCtD
Trimethoprim—Confusional state—Carmustine—lymphatic system cancer	0.000432	0.00225	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000428	0.00222	CcSEcCtD
Trimethoprim—Decreased appetite—Bleomycin—lymphatic system cancer	0.000427	0.00222	CcSEcCtD
Trimethoprim—Myalgia—Vincristine—lymphatic system cancer	0.000427	0.00222	CcSEcCtD
Trimethoprim—Cough—Mitoxantrone—lymphatic system cancer	0.000426	0.00221	CcSEcCtD
Trimethoprim—Vomiting—Fludarabine—lymphatic system cancer	0.000426	0.00221	CcSEcCtD
Trimethoprim—Convulsion—Mitoxantrone—lymphatic system cancer	0.000423	0.0022	CcSEcCtD
Trimethoprim—Rash—Fludarabine—lymphatic system cancer	0.000422	0.00219	CcSEcCtD
Trimethoprim—Dermatitis—Fludarabine—lymphatic system cancer	0.000422	0.00219	CcSEcCtD
Trimethoprim—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00042	0.00218	CcSEcCtD
Trimethoprim—Headache—Fludarabine—lymphatic system cancer	0.00042	0.00218	CcSEcCtD
Trimethoprim—Myalgia—Mitoxantrone—lymphatic system cancer	0.000416	0.00216	CcSEcCtD
Trimethoprim—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000416	0.00216	CcSEcCtD
Trimethoprim—Anxiety—Mitoxantrone—lymphatic system cancer	0.000414	0.00215	CcSEcCtD
Trimethoprim—Lethargy—Methotrexate—lymphatic system cancer	0.000412	0.00214	CcSEcCtD
Trimethoprim—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000409	0.00213	CcSEcCtD
Trimethoprim—Anorexia—Carmustine—lymphatic system cancer	0.000409	0.00212	CcSEcCtD
Trimethoprim—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000405	0.0021	CcSEcCtD
Trimethoprim—Confusional state—Mitoxantrone—lymphatic system cancer	0.000402	0.00209	CcSEcCtD
Trimethoprim—Nervous system disorder—Vincristine—lymphatic system cancer	0.000401	0.00209	CcSEcCtD
Trimethoprim—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000401	0.00208	CcSEcCtD
Trimethoprim—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000398	0.00207	CcSEcCtD
Trimethoprim—Nausea—Fludarabine—lymphatic system cancer	0.000398	0.00207	CcSEcCtD
Trimethoprim—Shock—Mitoxantrone—lymphatic system cancer	0.000392	0.00204	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000391	0.00203	CcSEcCtD
Trimethoprim—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00039	0.00203	CcSEcCtD
Trimethoprim—Urticaria—Bleomycin—lymphatic system cancer	0.00039	0.00203	CcSEcCtD
Trimethoprim—Anorexia—Vincristine—lymphatic system cancer	0.00039	0.00203	CcSEcCtD
Trimethoprim—Body temperature increased—Bleomycin—lymphatic system cancer	0.000388	0.00202	CcSEcCtD
Trimethoprim—Insomnia—Carmustine—lymphatic system cancer	0.000388	0.00201	CcSEcCtD
Trimethoprim—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000387	0.00201	CcSEcCtD
Trimethoprim—Dyspnoea—Carmustine—lymphatic system cancer	0.000382	0.00199	CcSEcCtD
Trimethoprim—Anorexia—Mitoxantrone—lymphatic system cancer	0.00038	0.00197	CcSEcCtD
Trimethoprim—Ataxia—Methotrexate—lymphatic system cancer	0.00038	0.00197	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000373	0.00194	CcSEcCtD
Trimethoprim—Decreased appetite—Carmustine—lymphatic system cancer	0.000373	0.00194	CcSEcCtD
Trimethoprim—Insomnia—Vincristine—lymphatic system cancer	0.00037	0.00192	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00037	0.00192	CcSEcCtD
Trimethoprim—Constipation—Carmustine—lymphatic system cancer	0.000367	0.0019	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000364	0.00189	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000363	0.00189	CcSEcCtD
Trimethoprim—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000362	0.00188	CcSEcCtD
Trimethoprim—Decreased appetite—Vincristine—lymphatic system cancer	0.000356	0.00185	CcSEcCtD
Trimethoprim—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000355	0.00185	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000353	0.00184	CcSEcCtD
Trimethoprim—Feeling abnormal—Carmustine—lymphatic system cancer	0.000353	0.00184	CcSEcCtD
Trimethoprim—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000351	0.00182	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000351	0.00182	CcSEcCtD
Trimethoprim—Constipation—Vincristine—lymphatic system cancer	0.00035	0.00182	CcSEcCtD
Trimethoprim—Pruritus—Bleomycin—lymphatic system cancer	0.000347	0.00181	CcSEcCtD
Trimethoprim—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000346	0.0018	CcSEcCtD
Trimethoprim—Eosinophilia—Methotrexate—lymphatic system cancer	0.000346	0.0018	CcSEcCtD
Trimethoprim—Pancreatitis—Methotrexate—lymphatic system cancer	0.000342	0.00178	CcSEcCtD
Trimethoprim—Constipation—Mitoxantrone—lymphatic system cancer	0.000341	0.00177	CcSEcCtD
Trimethoprim—Body temperature increased—Carmustine—lymphatic system cancer	0.000339	0.00176	CcSEcCtD
Trimethoprim—Abdominal pain—Carmustine—lymphatic system cancer	0.000339	0.00176	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000335	0.00174	CcSEcCtD
Trimethoprim—Pancytopenia—Methotrexate—lymphatic system cancer	0.000332	0.00172	CcSEcCtD
Trimethoprim—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000328	0.00171	CcSEcCtD
Trimethoprim—Neutropenia—Methotrexate—lymphatic system cancer	0.000326	0.0017	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000326	0.00169	CcSEcCtD
Trimethoprim—Abdominal pain—Vincristine—lymphatic system cancer	0.000323	0.00168	CcSEcCtD
Trimethoprim—Body temperature increased—Vincristine—lymphatic system cancer	0.000323	0.00168	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000319	0.00166	CcSEcCtD
Trimethoprim—Urticaria—Mitoxantrone—lymphatic system cancer	0.000317	0.00165	CcSEcCtD
Trimethoprim—Hypersensitivity—Carmustine—lymphatic system cancer	0.000316	0.00164	CcSEcCtD
Trimethoprim—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000315	0.00164	CcSEcCtD
Trimethoprim—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000315	0.00164	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—lymphatic system cancer	0.000313	0.00163	CcSEcCtD
Trimethoprim—Vomiting—Bleomycin—lymphatic system cancer	0.000312	0.00162	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—lymphatic system cancer	0.000311	0.00162	CcSEcCtD
Trimethoprim—Infestation—Methotrexate—lymphatic system cancer	0.000311	0.00162	CcSEcCtD
Trimethoprim—Depression—Methotrexate—lymphatic system cancer	0.00031	0.00161	CcSEcCtD
Trimethoprim—Rash—Bleomycin—lymphatic system cancer	0.00031	0.00161	CcSEcCtD
Trimethoprim—Dermatitis—Bleomycin—lymphatic system cancer	0.000309	0.00161	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000309	0.0016	CcSEcCtD
Trimethoprim—Renal failure—Methotrexate—lymphatic system cancer	0.000306	0.00159	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—lymphatic system cancer	0.000303	0.00158	CcSEcCtD
Trimethoprim—Hypersensitivity—Vincristine—lymphatic system cancer	0.000301	0.00157	CcSEcCtD
Trimethoprim—Haematuria—Methotrexate—lymphatic system cancer	0.000297	0.00154	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000294	0.00153	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—lymphatic system cancer	0.000294	0.00153	CcSEcCtD
Trimethoprim—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000294	0.00153	CcSEcCtD
Trimethoprim—Diarrhoea—Carmustine—lymphatic system cancer	0.000293	0.00152	CcSEcCtD
Trimethoprim—Nausea—Bleomycin—lymphatic system cancer	0.000292	0.00152	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000291	0.00151	CcSEcCtD
Trimethoprim—Dizziness—Carmustine—lymphatic system cancer	0.000283	0.00147	CcSEcCtD
Trimethoprim—Diarrhoea—Vincristine—lymphatic system cancer	0.00028	0.00145	CcSEcCtD
Trimethoprim—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000276	0.00143	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—lymphatic system cancer	0.000274	0.00142	CcSEcCtD
Trimethoprim—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000273	0.00142	CcSEcCtD
Trimethoprim—Vomiting—Carmustine—lymphatic system cancer	0.000273	0.00142	CcSEcCtD
Trimethoprim—Dizziness—Vincristine—lymphatic system cancer	0.000271	0.00141	CcSEcCtD
Trimethoprim—Rash—Carmustine—lymphatic system cancer	0.00027	0.0014	CcSEcCtD
Trimethoprim—Dermatitis—Carmustine—lymphatic system cancer	0.00027	0.0014	CcSEcCtD
Trimethoprim—Headache—Carmustine—lymphatic system cancer	0.000269	0.0014	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000264	0.00137	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—lymphatic system cancer	0.000261	0.00136	CcSEcCtD
Trimethoprim—Tinnitus—Methotrexate—lymphatic system cancer	0.000261	0.00135	CcSEcCtD
Trimethoprim—Vomiting—Vincristine—lymphatic system cancer	0.00026	0.00135	CcSEcCtD
Trimethoprim—Rash—Vincristine—lymphatic system cancer	0.000258	0.00134	CcSEcCtD
Trimethoprim—Dermatitis—Vincristine—lymphatic system cancer	0.000258	0.00134	CcSEcCtD
Trimethoprim—Headache—Vincristine—lymphatic system cancer	0.000256	0.00133	CcSEcCtD
Trimethoprim—Nausea—Carmustine—lymphatic system cancer	0.000255	0.00132	CcSEcCtD
Trimethoprim—Vomiting—Mitoxantrone—lymphatic system cancer	0.000253	0.00132	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—lymphatic system cancer	0.000252	0.00131	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000252	0.00131	CcSEcCtD
Trimethoprim—Rash—Mitoxantrone—lymphatic system cancer	0.000251	0.00131	CcSEcCtD
Trimethoprim—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000251	0.0013	CcSEcCtD
Trimethoprim—Headache—Mitoxantrone—lymphatic system cancer	0.00025	0.0013	CcSEcCtD
Trimethoprim—Mental disorder—Methotrexate—lymphatic system cancer	0.000245	0.00127	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—lymphatic system cancer	0.000243	0.00126	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—lymphatic system cancer	0.000243	0.00126	CcSEcCtD
Trimethoprim—Nausea—Vincristine—lymphatic system cancer	0.000243	0.00126	CcSEcCtD
Trimethoprim—Nausea—Mitoxantrone—lymphatic system cancer	0.000237	0.00123	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—lymphatic system cancer	0.000219	0.00114	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—lymphatic system cancer	0.000218	0.00113	CcSEcCtD
Trimethoprim—Cough—Methotrexate—lymphatic system cancer	0.000212	0.0011	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—lymphatic system cancer	0.000211	0.0011	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—lymphatic system cancer	0.000207	0.00108	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—lymphatic system cancer	0.000207	0.00108	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000206	0.00107	CcSEcCtD
Trimethoprim—Confusional state—Methotrexate—lymphatic system cancer	0.0002	0.00104	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000199	0.00103	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000195	0.00101	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000194	0.00101	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—lymphatic system cancer	0.000193	0.001	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—lymphatic system cancer	0.000189	0.000984	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000181	0.00094	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—lymphatic system cancer	0.00018	0.000933	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—lymphatic system cancer	0.000177	0.00092	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—lymphatic system cancer	0.000175	0.000908	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—lymphatic system cancer	0.000173	0.000897	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000171	0.000891	CcSEcCtD
Trimethoprim—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000164	0.00085	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000162	0.000844	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—lymphatic system cancer	0.000158	0.00082	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—lymphatic system cancer	0.000157	0.000816	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—lymphatic system cancer	0.000157	0.000816	CcSEcCtD
Trimethoprim—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000146	0.00076	CcSEcCtD
Trimethoprim—Pruritus—Methotrexate—lymphatic system cancer	0.00014	0.00073	CcSEcCtD
Trimethoprim—Diarrhoea—Methotrexate—lymphatic system cancer	0.000136	0.000706	CcSEcCtD
Trimethoprim—Dizziness—Methotrexate—lymphatic system cancer	0.000131	0.000682	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—lymphatic system cancer	0.000126	0.000656	CcSEcCtD
Trimethoprim—Rash—Methotrexate—lymphatic system cancer	0.000125	0.000651	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—lymphatic system cancer	0.000125	0.00065	CcSEcCtD
Trimethoprim—Headache—Methotrexate—lymphatic system cancer	0.000124	0.000646	CcSEcCtD
Trimethoprim—Nausea—Methotrexate—lymphatic system cancer	0.000118	0.000613	CcSEcCtD
